Bioasis' Transcend program attracts the first big Pharma. Notice this is more then a collab agreement. This is an option to license the product. Transcend has been independently verified as efficacious in delivering biologics across teh blood brain barrier. This is the holy grail as far as the CNS research is concerned. Bioasis holds the key to delivering innumerable therapies to the brain. This will likely be the first of many agreements to come. Fantastic development, an an excellent investment opportunity under 0.60.TB